An updated meta-analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease

被引:6
|
作者
Baratto, Claudia [1 ]
Caravita, Sergio [1 ,2 ]
Soranna, Davide [3 ]
Dewachter, Celine [4 ]
Bondue, Antoine [4 ]
Zambon, Antonella [3 ,5 ]
Badano, Luigi P. [1 ,6 ]
Parati, Gianfranco [1 ,6 ]
Vachiery, Jean-Luc [4 ]
机构
[1] Osped San Luca, Dept Cardiovasc Neural & Metab Sci, Ist Auxol Italiano IRCCS, Milan, Italy
[2] Univ Bergamo, Dept Management Informat & Prod Engn, Dalmine, BG, Italy
[3] IRCCS Ist Auxol Italiano, Biostat Unit, Milan, Italy
[4] Clin Univ Bruxelles, Hop Acad Erasme, Dept Cardiol, Brussels, Belgium
[5] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Milan, Italy
[6] Univ Milano Bicocca, Dept Med & Surg, Milan, Italy
关键词
hemodynamics; pulmonary hypertension; left heart disease; prognosis; RIGHT-VENTRICULAR FUNCTION; ARTERIAL CAPACITANCE; PRESSURE-GRADIENT; FAILURE; LEVOSIMENDAN; PREDICTOR; OUTCOMES; BIAS;
D O I
10.1002/pul2.12145
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary hypertension (PH) is associated with a poor prognosis in left heart disease (LHD). We sought to provide an updated analysis on the association of hemodynamic variables, such as pulmonary vascular resistance (PVR), pulmonary artery compliance (PAC), and diastolic pressure gradient (DPG), with prognosis in PH-LHD, through a systematic literature review. Sixteen articles were identified, including 9600 patients with LHD, heterogeneous in terms of age, sex, and etiology of cardiac disease. In this large population, PVR (hazard ratio [HR], 1.07; 95% confidence interval [CI]: 1.05-1.0), DPG (HR, 1.02; 95% CI: 1.01-1.02) and PAC (HR, 0.76; 95% CI: 0.69-0.84) were associated with an increased risk of adverse outcome, albeit with a less solid performance of DPG. Similar results were found when hemodynamic variables were analyzed according to the thresholds commonly applied in clinical practice, or subdividing cohorts according to the underlying LHD. Furthermore, cumulative metanalysis indicated that these results are consistently stable since 2018. Thus, PVR, DPG and PAC have an established prognostic value in PH-LHD. These results are consistent through the years and unlikely to change with further studies.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018
    Rosenkranz, Stephan
    Lang, Irene M.
    Blindt, Ruediger
    Bonderman, Diana
    Bruch, Leonhard
    Diller, Gerhard P.
    Felgendreher, Ralf
    Gerges, Christian
    Hohenforst-Schmidt, Wolfgang
    Holt, Stephan
    Jung, Christian
    Kindermann, Ingrid
    Kramer, Tilmann
    Kuebler, Wolfgang M.
    Mitrovic, Veselin
    Riedel, Andreas
    Rieth, Andreas
    Schmeisser, Alexander
    Wachter, Rolf
    Weil, Joachim
    Opitz, Christian F.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 272 : 53 - 62
  • [32] Pulmonary hypertension caused by left heart disease
    Erer, Betul
    Eren, Mehmet
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2010, 10 : 42 - 46
  • [33] Pulmonary Hypertension Owing to Left Heart Disease
    Mathier, Michael A.
    CLINICS IN CHEST MEDICINE, 2013, 34 (04) : 683 - +
  • [34] Pulmonary hypertension in left heart disease: A review
    Corte, Tamera J.
    McDonagh, Theresa A.
    Wort, Stephen J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 156 (03) : 253 - 258
  • [35] The assessment of left heart disease in patients with systemic sclerosis and pulmonary hypertension
    Ninagawa, K.
    Kato, M.
    Ohira, H.
    Tsuneta, S.
    Iwano, H.
    Kono, M.
    Fujieda, Y.
    Oku, K.
    Tsujino, I
    Atsumi, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (04) : S103 - S110
  • [36] Effectiveness of Sildenafil in Pulmonary Hypertension Secondary to Valvular Heart Disease: A Systematic Review and Meta-Analysis
    Ghaffar, Farizan Abdul
    Redzuan, Adyani Md
    Makmor-Bakry, Mohd
    ARCHIVES OF PHARMACY PRACTICE, 2021, 12 (03) : 55 - 65
  • [37] Pulmonary hypertension due to left heart disease: Recommendations of the Cologne Consensus Conference 2010
    Rosenkranz, S.
    Bonderman, D.
    Buerke, M.
    Felgendreher, R.
    ten Freyhaus, H.
    Gruenig, E.
    de Haan, F.
    Hammerstingl, C.
    Harreuter, A.
    Hohenforst-Schmidt, W.
    Kindermann, I.
    Kindermann, M.
    Kleber, F. -X.
    Kuckeland, M.
    Kuebler, W. M.
    Mertens, D.
    Mitrovic, V.
    Opitz, C.
    Schmeisser, A.
    Schulz, U.
    Speich, R.
    Zeh, W.
    Weil, J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2010, 135 : S102 - S114
  • [38] Prevalence of pulmonary hypertension in patients with chronic kidney disease without dialysis: a meta-analysis
    Shang, Weifeng
    Li, Yuanyuan
    Ren, Yali
    Li, Wei
    Wei, HongLan
    Dong, Junwu
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (08) : 1497 - 1504
  • [39] Pulmonary Hypertension Due to Left Heart Diseases
    Vachiery, Jean-Luc
    Adir, Yochai
    Albert Barbera, Joan
    Champion, Hunter
    Coghlan, John Gerard
    Cottin, Vincent
    De Marco, Teresa
    Galie, Nazzareno
    Ghio, Stefano
    Gibbs, J. Simon R.
    Martinez, Fernando
    Semigran, Marc
    Simonneau, Gerald
    Wells, Athol
    Seeger, Werner
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (25) : D100 - D108
  • [40] Pulmonary vascular reactivity in pulmonary hypertension due to left heart disease
    Gerges, Christian
    Gerges, Mario
    Lang, Marie
    Mascherbauer, Julia
    Lang, Irene
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42